# Pivotal Study of the Velocity™ pAVF System

Study · id `cardio:ct-nct07153939` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07153939](<https://clinicaltrials.gov/study/NCT07153939>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07153939

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 126 participants.

## Technical summary

Registry record NCT07153939. Allocation not applicable; no masking; primary purpose treatment. Start 2025-10-21 (actual); primary completion 2026-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 126 participants (planned count; ClinicalTrials.gov record NCT07153939, source copy `cardio:ctgov-nct07153939-2026-09-02`, retrieved 2026-10-26)
- Started: 2025-10-21 (actual) (ClinicalTrials.gov record NCT07153939, source copy `cardio:ctgov-nct07153939-2026-09-02`, retrieved 2026-10-26)
- Primary completion: 2026-09 (anticipated) (ClinicalTrials.gov record NCT07153939, source copy `cardio:ctgov-nct07153939-2026-09-02`, retrieved 2026-10-26)
- Completion: 2030-09 (anticipated) (ClinicalTrials.gov record NCT07153939, source copy `cardio:ctgov-nct07153939-2026-09-02`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07153939, source copy `cardio:ctgov-nct07153939-2026-09-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07153939-2026-09-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pivotal Study of the Velocity™ pAVF System
- Acronym: VENOS-3
- Condition: Chronic Kidney Disease
- Condition: Hemodialysis Access
- Condition: Arteriovenous Fistula
- Condition: End Stage Renal Disease (ESRD)
- Intervention (Device): Velocity Percutaneous Arteriovenous Fistula
- Lead sponsor: Venova Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 37d247931a8e99ee7e22070a218e214937b6ca1613db28c8f2fda189e622d501
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
